Standard Biotools (LAB) Free Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.80% |
| Dec 31, 2025 | 19.14% |
| Sep 30, 2025 | -36.13% |
| Jun 30, 2025 | -45.74% |
| Mar 31, 2025 | -46.01% |
| Dec 31, 2024 | -19.94% |
| Sep 30, 2024 | -34.65% |
| Jun 30, 2024 | -49.81% |
| Mar 31, 2024 | -25.40% |
| Dec 31, 2023 | -76.62% |
| Sep 30, 2023 | -23.65% |
| Jun 30, 2023 | -18.24% |
| Mar 31, 2023 | 10.19% |
| Dec 31, 2022 | -112.45% |
| Sep 30, 2022 | -24.83% |
| Jun 30, 2022 | -29.68% |
| Mar 31, 2022 | -12.38% |
| Dec 31, 2021 | 46.52% |
| Sep 30, 2021 | -27.20% |
| Jun 30, 2021 | -34.23% |
| Mar 31, 2021 | -17.28% |
| Dec 31, 2020 | -19.84% |
| Sep 30, 2020 | 17.52% |
| Jun 30, 2020 | 17.96% |
| Mar 31, 2020 | 13.04% |
| Dec 31, 2019 | -3.74% |
| Sep 30, 2019 | 10.42% |
| Jun 30, 2019 | -17.38% |
| Mar 31, 2019 | -10.54% |
| Dec 31, 2018 | -19.97% |
| Sep 30, 2018 | -16.80% |
| Jun 30, 2018 | -9.07% |
| Mar 31, 2018 | -59.35% |
| Dec 31, 2017 | 16.14% |
| Sep 30, 2017 | -18.08% |
| Jun 30, 2017 | -11.73% |
| Mar 31, 2017 | -5.45% |
| Dec 31, 2016 | -31.24% |
| Sep 30, 2016 | -41.26% |
| Jun 30, 2016 | 6.13% |
| Mar 31, 2016 | -43.88% |
| Dec 31, 2015 | -16.95% |
| Sep 30, 2015 | -28.50% |